Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections

Diagnostic Microbiology and Infectious Disease

Volumn 56, Issue 3, 2006, Pages 297-303

  Iihara, Hirotoshi ^a,b   Suzuki, Takashi ^c   Kawamura, Yoshiaki ^d   Ohkusu, Kiyofumi ^a   Inoue, Yasushi ^e   Zhang, Wei ^c   Monir Shah, Mohammad ^a   Katagiri, Yoshihiro ^a,b   Ohashi, Yuichi ^c   Ezaki, Takayuki ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d AICHI GAKUIN UNIVERSITY   (Japan)

^e Inoue Eye Clin   (Japan)

Author keywords

Fluoroquinolone; Methicillin resistant Staphylococcus aureus; Mutation; Ocular infection; Ophthalmic solution; Resistant

Indexed keywords

GATIFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; EYE INFECTION; GENE MUTATION; GYRA GENE; GYRB GENE; GYRLA GENE; GYRLB GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE;

DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; EYE INFECTIONS; FLUOROQUINOLONES; GENES, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33750447026     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.04.017     Document Type: Article

References (36)

1. Bannerman T.L., Hancock G.A., Tenover F.C., and Miller J.M. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33 (1995) 551-555
2. Bannerman T.L. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically. In: Murray P.R., Baron E.J., Pfaller M.A., Jorgensen J.H., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 8th ed (2003), American Society for Microbiology, Washington (DC) 384-404
3. Clinical Laboratory Standards Institute. Performance standards for antimicrobial sensitivity testing. Approved standard CLSI document M100-S14 (2004), Clinical Laboratory Standards Institute, Villanova (PA)
4. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard CLSI document M7-A7 (2006), Clinical Laboratory Standards Institute, Villanova (PA)
5. Clinical Laboratory Standards Institute. Performance standards for antimicrobial sensitivity testing. Approved standard CLSI document M100-S16 (2006), Clinical Laboratory Standards Institute, Villanova (PA)
6. Ezaki T., Saidi S.M., Liu S.L., Hashimoto Y., Yamamoto H., and Yabuuchi E. Rapid procedure to determine the DNA base composition from small amounts of Gram-positive bacteria. FEMS Microbiol. Lett. 55 (1990) 127-130
7. Goering R.V., and Winters M.A. Rapid method for epidemiological evaluation of Gram-positive cocci by field inversion gel electrophoresis. J. Clin. Microbiol. 30 (1992) 577-580
8. Goldstein M.H., Kowalski R.P., and Gordon Y.J. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 106 (1999) 1313-1318
9. Guirao G.Y., Martinez Toldos M.C., Mora Peris B., Alonso Manzanares M.A., Gutiérrez Zufiaurre M.N., Martínez Andrés J.A., Muñoz Bellido J.L., García-Rodríguez J.A., and Hernández S. Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones. J. Antimicrob. Chemother. 47 (2001) 157-161
10. Hooper D.C. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 31 Suppl. 2 (2000) S24-S28
11. Hooper D.C. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect. Dis. 2 (2002) 530-538
12. Horii T., Suzuki Y., Monji A., Morita M., Muramatsu H., Kondo Y., Doi M., Takeshita A., Kanno T., and Maekawa M. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs. Diagn. Microbiol. Infect. Dis. 46 (2003) 139-145
13. Ito H., Yoshida H., Bogaki-Shonai M., Niga T., Hattori H., and Nakamura S. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob. Agents Chemother. 38 (1994) 2014-2023
14. Jones M.E., Critchley I.A., Karlowsky J.A., Blosser-Middleton R.S., Schmitz F.J., Thornsberry C., and Sahm D.F. In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV. Antimicrob. Agents Chemother. 46 (2002) 1651-1657
15. Kaatz G.W., Seo S.M., and Ruble C.A. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37 (1993) 1086-1094
16. Kaatz G.W., and Seo S.M. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 39 (1995) 2650-2655
17. Kowalski R.P., Karenchak L.M., and Gordon Y.J. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels. Cornea 17 (1998) 282-287
18. Kowalski R.P., Pandya A.N., Karenchak L.M., Romanowski E.G., Husted R.C., Ritterband D.C., Shah M.K., and Gordon Y.J. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology 108 (2001) 1826-1829
19. Kowalski R.P., Dhaliwal D.K., Karenchak L.M., Romanowski E.G., Mah F.S., Ritterband D.C., and Gordon Y.J. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am. J. Ophthalmol. 136 (2003) 500-505
20. Marangon F.B., Miller D., Muallem M.S., Romano A.C., and Alfonso E.C. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am. J. Ophthalmol. 137 (2004) 453-458
21. Mather R., Karenchak L.M., Romanowski E.G., and Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am. J. Ophthalmol. 133 (2002) 463-466
22. Morrissey I., Burnett R., Viljoen L., and Robbins M. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. J. Infect. 49 (2004) 109-114
23. Ng E.Y., Trucksis M., and Hooper D.C. Quinolone resistance mutation in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40 (1996) 1881-1888
24. Noguchi N., Okihara T., Namiki Y., Kumaki Y., Yamanaka Y., Koyama M., Wakasugi K., and Sasatsu M. Susceptibility and resistance genes to fluoroquinolone in methicillin-resistant Staphylococcus aureus isolated in 2002. Int. J. Antimicrob. Agents 25 (2005) 374-379
25. Romanowski E.G., Mah F.S., Yates K.A., Kowalski R.P., and Gordon Y.J. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model. Am. J. Ophthalmol. 139 (2005) 867-877
26. Schmitz F.J., Jones M.E., Hofmann B., Hansen B., Scheuring S., Lückefahr M., Fluit A.D., Verhoef J., Hadding U., Heinz H.P., and Köhrer K. Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42 (1998) 1249-1252
27. Schmitz F.J., Fluit A.C., Lückefahr M., Engler B., Hofmann B., Verhoef J., Heinz H.P., Hadding U., and Jones M.E. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 42 (1998) 807-810
28. Sierra J.M., Marco F., Ruiz J., Jiménez de Anta M.T., and Vila J. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus. Clin. Microbiol. Infect. 8 (2002) 781-790
29. Takei M., Fukuda H., Kishii R., and Hosaka M. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition. Antimicrob. Agents Chemother. 45 (2001) 3544-3547
30. Tanaka M., Onodera Y., Uchida Y., and Sato K. Quinolone resistance mutations in the GrlB protein of Staphylococcus aureus. Antimicrob. Agents Chemother. 42 (1998) 3044-3046
31. Tanaka M., Wang T., Onodera Y., Uchida Y., and Sato K. Mechanism of quinolone resistance in Staphylococcus aureus. J. Infect. Chemother. 6 (2000) 131-139
32. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
33. Trucksis M., Wolfson J.S., and Hooper D.C. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J. Bacteriol. 173 (1991) 5854-5860
34. Wang T., Tanaka M., and Sato K. Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob. Agents Chemother. 42 (1998) 236-240
35. Yamagishi J., Kojima T., Oyamada Y., Fujimoto K., Hattori H., Nakamura S., and Inoue M. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40 (1996) 1157-1163
36. Yoshida H., Bogaki M., Nakamura S., Ubukata K., and Konno M. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172 (1990) 6942-6949